Life Sciences Commercial Banker in San Diego, CA

Supporting San Diego–based life science companies from Series A through commercialization at J.P. Morgan

About

I am a life sciences commercial banker at J.P. Morgan, working with companies headquartered in San Diego across the life sciences ecosystem. I partner with CEOs and CFOs navigating growth, runway, and increasing financial complexity.Scientific timelines shift. Programs pivot. Data opens new options. The leaders I work with need banking relationships that can adapt as those needs evolve, rather than financial infrastructure that has to be rebuilt at each stage.I work with pharmaceutical, biotechnology, medical technology, diagnostics, genomics, and life science services companies from Series A through commercialization. My coverage extends through later stages as well, including public life science companies that are pre-revenue or fully commercialized. While I primarily work with companies headquartered in San Diego, I support their expansion nationally and globally.One advantage of the J.P. Morgan platform is continuity across stages of growth. As companies scale, they can work with a single institution that supports day-to-day banking and global treasury needs, and, when appropriate, access broader firm capabilities, without losing context or rebuilding relationships at key inflection points.Kon Theodoridis is a life sciences commercial banker at J.P. Morgan, working with San Diego–based pharmaceutical, biotechnology, medical device, diagnostics, genomics, and life science services companies.

Areas of Focus

I work with life science leadership teams on the financial infrastructure required to support growth and prepare for key milestones on the path to commercialization.

  • Commercial banking for life science companies: Supporting biotech, pharmaceutical, and medical device firms across growth stages

  • Cash management and treasury structure: Designing scalable financial infrastructure as complexity increases

  • Preparing for commercialization and post-approval scale: Supporting companies as they transition from development to revenue

  • Supporting national and global expansion: Including international treasury and operating complexity

  • Coordinating access to broader J.P. Morgan capabilities: Including commercial banking, asset management, investment banking, and private banking when appropriate

FAQ

What types of life science companies do you work with?
I work with a broad range of life science companies, including:Pharmaceutical and Biotechnology Companies: From traditional small-molecule pharmaceutical firms to biotechnology companies focused on biologics, vaccines, and advanced gene and cell therapies.Medical Technology Companies: Developers and manufacturers of medical devices, including implants, surgical technologies, diagnostic imaging systems, and patient monitoring solutions.Diagnostics and Genomics Companies: Organizations focused on molecular diagnostics, next-generation sequencing (NGS), and precision medicine.Life Science Service and Support Organizations: Industry partners such as Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs).At what stage should a life science company engage a commercial banker?
My coverage begins at Series A and extends through later stages of growth, including public life science companies that are pre-revenue or fully commercialized.Do you only work with San Diego–based companies?
I primarily work with life science companies headquartered in San Diego, while supporting their operations as they scale nationally and globally.How does working with J.P. Morgan support companies as they grow?
As companies scale, the J.P. Morgan platform provides continuity and coordinated access to capabilities that may become relevant over time. These can include commercial banking, global treasury solutions, asset management, investment banking services, and private banking for investors and senior leadership, as appropriate and subject to internal processes and approvals.What areas do you typically help leadership teams think through?
My work focuses on helping leadership teams design financial infrastructure that evolves with the business. This often includes cash management and treasury structure, preparing for commercialization milestones, supporting expansion into new markets, and evaluating tools such as corporate cards or venture debt solutions when appropriate. The objective is to align financial structure with increasing operational complexity.How can a CEO or CFO get in touch?
If you are a life science CEO or CFO based in San Diego and would like to explore a banking relationship, you can reach out using the contact options listed below.

Contact

If you are a CEO or CFO of a Series A or later life science company headquartered in San Diego and would like to explore a banking relationship, you can reach out via Email or LinkedIn below.

Disclaimer

Banking products and services are provided by J.P. Morgan and its affiliates.This is a personal site for informational purposes only and does not constitute an offer, solicitation, recommendation, or investment advice. Any products or services referenced are subject to applicable laws, regulations, and internal approvals. Views expressed are my own and do not necessarily reflect the views of J.P. Morgan. Not all products and services are available in all jurisdictions or to all clients.